Amanda Hyre Anderson, PhD, MPH

Dr. Anderson’s major research interests address the epidemiology of kidney diseases, with an emphasis on the causes and consequences of the excessive morbidity and mortality experienced by patients with chronic kidney disease (CKD). She has a particular focus on factors associated with CKD progression including fibrosis measures and the gut microbiome, prediction of kidney function decline over time, and the insufficiently characterized burden of co-morbidities and outcomes associated with CKD. Dr. Anderson is the principal investigator of two NIH/NIDDK R01 studies to investigate blood and urine fibrosis measures as predictors of CKD progression and cardiovascular disease in the setting of CKD, and to examine associations between the gut microbiome, plasma and fecal metabolomes, and CKD progression. She has over 10 years of experience providing scientific and operational leadership to Scientific and Data Coordinating Centers of large, multi-center studies examining risk factors for cardiovascular disease and progression of kidney disease among adults with CKD. Dr. Anderson also serves as the Associate Director of the Tulane University Translational Science Institute.

Please view Dr. Anderson's publications at her NCBI profile page.